Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Molecular Insight Pharmaceuticals, Inc.
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provide written informed consent and are willing to comply with protocol requirements
Are 40 years of age or older.
Are being evaluated for possible ACS.
If female, then not of childbearing potential as documented by history or has a negative serum or urine pregnancy test within 4 hours prior to receiving the test drug and agrees to use an acceptable form of birth control.
You may not be if
\<40 years of age.
Females who are pregnant or lactating.
History of left ventricular ejection fraction (LVEF)=40%.
History of MI.
Acute ST segment elevation on ECG.
Left bundle branch block on ECG.
Known history of significant allergy to x-ray contrast media or iodine/iodides.
Currently or formerly on medication that targets fatty acid uptake or metabolism, eg ranolazine, (Ranexa).
Administered radiopharmaceutical other than rubidium-82 or thallium-201 within 2 days prior to study enrollment.
Underwent cardiac stress testing of any kind within 2 days prior to study enrollment.
Serum creatinine level \>2.0 mg per dL.
Received investigational compound and/or medical device within 30 days of admission into this study.
